Vikas Jhawat

753 total citations
57 papers, 503 citations indexed

About

Vikas Jhawat is a scholar working on Pharmaceutical Science, Endocrinology, Diabetes and Metabolism and Molecular Medicine. According to data from OpenAlex, Vikas Jhawat has authored 57 papers receiving a total of 503 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pharmaceutical Science, 12 papers in Endocrinology, Diabetes and Metabolism and 10 papers in Molecular Medicine. Recurrent topics in Vikas Jhawat's work include Advanced Drug Delivery Systems (13 papers), Advancements in Transdermal Drug Delivery (10 papers) and Drug Solubulity and Delivery Systems (6 papers). Vikas Jhawat is often cited by papers focused on Advanced Drug Delivery Systems (13 papers), Advancements in Transdermal Drug Delivery (10 papers) and Drug Solubulity and Delivery Systems (6 papers). Vikas Jhawat collaborates with scholars based in India, Saudi Arabia and Oman. Vikas Jhawat's co-authors include Vipin Saini, Sumeet Gupta, Sunil Kamboj, Rohit Dutt, Balaji Maddiboyina, Suman Bala, Gandhi Sivaraman, Sima Singh, Rahul Pratap Singh and Partha Roy and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Controlled Release and International Journal of Biological Macromolecules.

In The Last Decade

Vikas Jhawat

49 papers receiving 479 citations

Peers

Vikas Jhawat

BIOMA

Sally A. El‐Zahaby Egypt

Kushagra Khanna India

Khuriah Abdul Hamid Malaysia

Swati Sharma India

Mayank Sharma India

Heba A. Hazzah Egypt

Poonam Kushwaha India

Ritu Karwasra India

Rasheed A. Shaik Saudi Arabia

Wensheng Zheng China

Sally A. El‐Zahaby Egypt

Vikas Jhawat

280 ×1.4

176 ×1.3

100 ×1.3

BIOMA

55 ×0.9

47 ×1.1

Citations per year, relative to Vikas Jhawat Vikas Jhawat (= 1×) peers Sally A. El‐Zahaby

Countries citing papers authored by Vikas Jhawat

Since Specialization

Citations

This map shows the geographic impact of Vikas Jhawat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vikas Jhawat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vikas Jhawat more than expected).

Fields of papers citing papers by Vikas Jhawat

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vikas Jhawat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vikas Jhawat. The network helps show where Vikas Jhawat may publish in the future.

Co-authorship network of co-authors of Vikas Jhawat

This figure shows the co-authorship network connecting the top 25 collaborators of Vikas Jhawat. A scholar is included among the top collaborators of Vikas Jhawat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vikas Jhawat. Vikas Jhawat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Deepshikha, Deepshikha, M. Lamba, Vikas Jhawat, et al.. (2025). An Overview of Hypertension: Pathophysiology, Risk Factors, and Modern Management. Current Hypertension Reviews. 21(2). 64–81. 2 indexed citations

Jhawat, Vikas, Samrat Chauhan, Rubina Bhutani, et al.. (2025). Hyaluronate-coated TPGS-g-chitosan nanoparticles for rheumatoid arthritis therapy: pharmaceutical development, anti-inflammatory activities, and bone regeneration studies. International Journal of Biological Macromolecules. 335(Pt 2). 149303–149303.

Singh, Sachin Kumar, et al.. (2025). Pathophysiology and emerging therapeutic strategies for cervical spondylosis: The role of pro-inflammatory mediators, kinase inhibitors, and Organogel based drug delivery systems. International Immunopharmacology. 151. 114350–114350. 1 indexed citations

Lamba, M., et al.. (2024). Development and characterization of a gallic acid-infused topical emulgel for enhanced wound management: formulation and i n vitro optimization. 2(2). 333–341. 1 indexed citations

Chauhan, Samrat, et al.. (2024). The interplay of skin architecture and cellular dynamics in wound healing: Insights and innovations in care strategies. Tissue and Cell. 91. 102578–102578. 7 indexed citations

Jhawat, Vikas, Rahul Pratap Singh, Sunita Chauhan, et al.. (2024). Development and In vitro Assessment of Topical Microemulsion BasedPluronic-Lecithin Organogel for the Management of Arthritic Pain. Micro and Nanosystems. 16(1). 36–45.

Maddiboyina, Balaji, et al.. (2023). Physiological Pathway, diagnosis and nanotechnology based treatment strategies for ovarian Cancer: A review. 8. 100020–100020. 9 indexed citations

Jhawat, Vikas, et al.. (2023). Comparative Materiovigilance Program for US, Europe, Japan, India and Proposed Reporting Mechanism for Indian Scenario. International Journal of Pharmaceutical Quality Assurance. 14(3). 534–540. 1 indexed citations

Jhawat, Vikas, et al.. (2022). Innovation in cancer therapeutics and regulatory perspectives. Medical Oncology. 39(5). 76–76. 48 indexed citations

10.

Singh, Rahul Pratap, et al.. (2022). Computer simulation in pharmaceutical research and drug development for pharmacokinetic and therapeutic optimization. Medical Journal Armed Forces India. 80(Suppl 1). S354–S355. 1 indexed citations

11.

Jhawat, Vikas, et al.. (2022). Utilization of kinase inhibitors as novel therapeutic drug targets: A review. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 30(5). 221–230. 17 indexed citations

12.

Maddiboyina, Balaji, et al.. (2021). Design expert assisted formulation, characterization and optimization of microemulsion based solid lipid nanoparticles of repaglinide. Progress in Biomaterials. 10(4). 309–320. 16 indexed citations

13.

Maddiboyina, Balaji, et al.. (2021). An insight of nanogels as novel drug delivery system with potential hybrid nanogel applications. Journal of Biomaterials Science Polymer Edition. 33(2). 262–278. 26 indexed citations

14.

Maddiboyina, Balaji, et al.. (2021). 3D Printing Technology in Pharmaceutical Dosage Forms: Advantages and Challenges. Current Drug Targets. 22(16). 1901–1914. 10 indexed citations

15.

Maddiboyina, Balaji, et al.. (2020). A Review on Nanoparticle Based Herbal Remedies for the Management of Alopecia. Der pharmacia lettre. 12(5). 1–17. 2 indexed citations

16.

Maddiboyina, Balaji, Vikas Jhawat, Aftab Alam, et al.. (2020). Formulation and evaluation of gastro-retentive floating bilayer tablet for the treatment of hypertension. Heliyon. 6(11). e05459–e05459. 32 indexed citations

17.

Jhawat, Vikas, et al.. (2020). Integration of pharmacogenomics and theranostics with nanotechnology as quality by design (QbD) approach for formulation development of novel dosage forms for effective drug therapy. Journal of Controlled Release. 327. 500–511. 17 indexed citations

18.

Jhawat, Vikas, et al.. (2017). 薬物送達システムの最適化のための医薬品のデザインと製剤の開発における薬理ゲノミクスのQuality by design(QbD)アプローチ. Journal of Controlled Release. 245. 26. 1 indexed citations

19.

Gupta, Sumeet & Vikas Jhawat. (2017). Induction of Type 2 Diabetes Mellitus with Antihypertensive Therapy: Is There Any Role of Alpha Adducin, ACE, and IRS-1 Gene?. Value in Health Regional Issues. 12. 90–98. 7 indexed citations

20.

Kamboj, Sunil, et al.. (2013). VESICULAR DRUG DELIVERY SYSTEMS: A NOVEL APPROACH FOR DRUG TARGETING. International Journal of Phytomedicine. 5(2). 121–130. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact